These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 14269682)
41. Stimulation of aromatization of exogenous and endogenous androgens in ovaries of hypophysectomized rats in vivo by follicle-stimulating hormone. Armstrong DT; Papkoff H Endocrinology; 1976 Oct; 99(4):1144-51. PubMed ID: 976193 [TBL] [Abstract][Full Text] [Related]
42. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Reyes FI; Winter JS; Faiman C Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845 [TBL] [Abstract][Full Text] [Related]
43. [ON THE TREATMENT OF PERIPHERAL CIRCULATORY DISORDERS WITH SEX HORMONES]. MOLLER J Med Welt; 1965 Jan; 3():181-2. PubMed ID: 14275264 [No Abstract] [Full Text] [Related]
44. [PHARMACOLOGY OF SEX HORMONES. II]. ALVES MA Gaz Med Port; 1964; 17():537-53. PubMed ID: 14291532 [No Abstract] [Full Text] [Related]
45. [Current views on treatment with estrogens]. Mirkov K; Kiutukchiev B Akush Ginekol (Sofiia); 1987; 26(3):1-7. PubMed ID: 3631423 [No Abstract] [Full Text] [Related]
46. Associations of LH and FSH with reproductive hormones depending on each stage of the menopausal transition. Kawakita T; Yasui T; Yoshida K; Matsui S; Iwasa T BMC Womens Health; 2023 May; 23(1):286. PubMed ID: 37231423 [TBL] [Abstract][Full Text] [Related]
47. Laboratory criteria for menopause in women using oral contraceptives. Creinin MD Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618 [TBL] [Abstract][Full Text] [Related]
48. [Therapy of essential vulvar pruritus of the woman in menopause by a combination of estrogens and androgens in the form of an aqueous suspension of microcrystals for parenteral injection]. ALAMANNI V Riv Ostet Ginecol Prat; 1956 May; 38(5):413-9. PubMed ID: 13380306 [No Abstract] [Full Text] [Related]
49. [FUNCTIONAL URINARY INCONTINENCE AND ITS TREATMENT]. NIKOLOV K Urol Mosc; 1964; 29():32-4. PubMed ID: 14175470 [No Abstract] [Full Text] [Related]
50. ESTROGEN IN THE TREATMENT OF ATHEROSCLEROSIS AND ITS SEQUELAE. MARMORSTON J; GRIFFITH GC Listing Res Cardiovasc Field; 1964; 10():392-9. PubMed ID: 24547501 [No Abstract] [Full Text] [Related]
51. [The use of combined estrogens and androgens in the therapy of some common gynecological disorders]. COZZI MV Minerva Med; 1952 Sep; 43(75):427-30. PubMed ID: 13012987 [No Abstract] [Full Text] [Related]
52. Estrogens around the menopause. Some metabolic aspects of clinical treatment. von Schoultz B Acta Obstet Gynecol Scand Suppl; 1985; 130():25-7. PubMed ID: 3859972 [No Abstract] [Full Text] [Related]
53. USE OF ESTROGEN IN THE TREATMENT OF ATHEROSCLEROSIS AND ITS SEQUELAE--A TEN-YEAR STUDY. MARMORSTON J; GRIFFITH GC Listing Res Cardiovasc Field; 1964; 10():399-401. PubMed ID: 24547502 [No Abstract] [Full Text] [Related]
55. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer. Bird CE; Cook S; Owen S; Sterns EE; Clark AF Oncology; 1981; 38(6):365-8. PubMed ID: 6795556 [TBL] [Abstract][Full Text] [Related]